Ledger.Open graph →
SEC Form D · Amendment · filed January 11, 2018

Stemgenics, Inc

Offering
$1.8M
Sold
$1.8M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SEATTLE, WA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

Andranik S. Aprikyan · Seattle, WAExec · DirectorMushegh S. Hovhannisyan · Seattle, WAExec · DirectorFrederick S. Hagen · Seattle, WAExec · DirectorGeneration Growth Capital Partners III, LLC · Milwaukee, WIExec · DirectorDavid Hite · Los Angeles, CAExec · DirectorAaron Skonnard · Farmington, UTExec · DirectorNate Walkingshaw · Farmington, UTExec · DirectorRyan Hinkle · Farmington, UTExec · DirectorMarcus Segal · Los Angeles, CAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗